Fascin expression predicts survival after potentially curative resection of node-positive colon cancer

American Journal of Surgical Pathology

Volumn 34, Issue 5, 2010, Pages 656-666

  Chan, Charles ^a   Jankova, Lucy ^c   Fung, Caroline L S ^a   Clarke, Candice ^a   Robertson, Graham ^c   Chapuis, Pierre H ^a   Bokey, Les ^a   Lin, Betty P C ^a   Dent, Owen F ^a   Clarke, Stephen ^b  

^a Department of Geriatric Medicine   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANZAC Research Institute   (United States)

Author keywords

Fascin; Prognosis; Stage C colon cancer; Survival

Indexed keywords

ACTIN BINDING PROTEIN; CARRIER PROTEIN; FASCIN; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; AUSTRALIA; COLON; COLON TUMOR; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADENOCARCINOMA; AGED; AUSTRALIA; CARRIER PROTEINS; COLON; COLONIC NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICROFILAMENT PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 77951875068     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181db36c0     Document Type: Article

References (45)

1. Adams J. Roles of fascin in cell adhesion and motility. Curr Opin Cell Biol. 2004;16:590-596. (Pubitemid 39201245)
2. Bakshi NA, Finn WG, Schnitzer B, et al. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classic Hodgkin lymphoma. Arch Pathol Lab Med. 2007;131:742-747. (Pubitemid 46726135)
3. Bokey EL, Chapuis PH, Dent OF, et al. Surgical technique in patients having a curative resection for colon cancer. Dis Colon Rectum. 2003;46:860-866.
4. Chen SF, Yang SF, Li JW, et al. Expression of fascin in oral and oropharyngeal squamous cell carcinoma has prognostic significance-a tissue microarray study of 129 cases. Histopathology. 2007;51: 173-183.
5. Choi PJ, Yang DK, Son CH, et al. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3cm of less in diameter. Eur J Car-diothorac Surg. 2006;30:538-542.
6. Darakhshan A, Lin BP, Chan C, et al. Correlates and outcomes of tumor adherence in resected colonic and rectal cancers. Ann Surg. 2008;247:650-658. (Pubitemid 351440616)
7. Davis NC, Newland RC. Terminology and classification of color-ectal adenocarcinoma: the Australian Clinico-pathological Staging System. Aust N Z J Surg. 1983;53:211-221. (Pubitemid 14226709)
8. Fielding LP, Arsenault PA, Chapuis PH, et al. Clinicopathological staging for colorectal cancer: An international documentation (IDS) and an international comprehensive anatomical terminology (ICAT). J Gastroenterol Hepatol. 1991;6:325-344.
9. Gabriel WB, Dukes C, Bussey HJR. Lymphatic spread in cancer of the rectum. Br J Surg. 1935;23:395-413.
10. Goncharuk VN, Ross JS, Carlson JA. Actin-binding protein fascin expression in skin neoplasia. J Cutan Pathol. 2002;29:430-438.
11. Grothey A, Hashizume R, Sahin AA, et al. Fascin, and actin bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br J Cancer. 2000;83: 870-873.
12. Hashimoto Y, Shimada Y, Kasamura J, et al. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology. 2004;67:262-670. (Pubitemid 38813047)
13. Hashimoto Y, Ito T, Okumura T, et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res. 2005;11:2597-2605. (Pubitemid 40569459)
14. Hashimoto Y, Skacel M, Adams JC. Roles of fascin in human carcinoma motility and signalling: prospects for a novel biomarker? Int J Biochem Cell Biol. 2005;37:1787-1804. (Pubitemid 40961664)
15. Hashimoto Y, Skacel M, Lavery IC, et al. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohisto-chemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 2006;6:241. (Pubitemid 44687821)
16. Hu W, McCrea PD, Deavers M, et al. Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors. Clin Exp Metastasis. 2000;18:83-88. (Pubitemid 32096054)
17. Jawhari AU, Buda A, Jenkins M, et al. Fascin, an anti-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol. 2003;162:69-80. (Pubitemid 36041990)
18. Jin SJ, Yu CP, Sun GH. Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histopathology. 2006;21:1287-1293.
19. Kabukcuoglu S, Onedr U, Ozalp SS, et al. The role of actin bundling protein fascin in the presentation of ovarian neoplasms. Eur J Gynaecol Oncol. 2006;27:171-176.
20. Kabukcuoglu S, Onedr U, Ozalp SS, et al. Prognostic significance of fascin expression in endometrioid carcinoma. Eur J Gynaecol Oncol. 2006;27:481-486.
21. Keshava A, Chapuis PH, Chan C, et al. The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis. 2007;9:609-618. (Pubitemid 47261826)
22. Kurieishy N, Sapountzi V, Prag S, et al. Fascins and their roles in cell structure and function. Bioessays. 2002;24:350-361. (Pubitemid 34305690)
23. Lee TK, Poon RT, Man K, et al. Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett. 2007;254:308-315. (Pubitemid 47135617)
24. Maitra A, Iacobuzio-Donahue C, Rahman A, et al. Immunohisto-chemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein. Am J Clin Pathol. 2004;118:52-59. (Pubitemid 34734252)
25. Mosialos G, Birkenbach M, Ayehuni S, et al. Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein. Am J Pathol. 1996;148:593-600. (Pubitemid 26056743)
26. Newland RC, Chapuis PH, Pheils MT, et al. The relationship of survival to staging and grading of colorectal carcinoma. A prospective study of 503 cases. Cancer. 1981;47:1424-1429.
27. Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging in colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer. 1987;60:852-857.
28. Okada K, Shimura T, Asakawa K, et al. Fascin expression is correlated with tumour progression of extrahepatic bile duct cancer. Hepatogastroenterology. 2007;54:17-21. (Pubitemid 46511638)
29. Pelosi G, Pasini F, Fraggetta F, et al. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer. 2003;42:203-213. (Pubitemid 37268031)
30. Pelosi G, Pastorini U, Pasini F, et al. Independent prognostic value of fascin immunoreactivity in stage I non-small-cell lung cancer. Br J Cancer. 2003;88:537-547. (Pubitemid 36363363)
31. Peraud A, Mondal S, Hawkins C, et al. Expression of fascin, and actin-bundling protein, in astrocytomas of varying grades. Brain Tumor Pathol. 2003;20:53-58. (Pubitemid 38146271)
32. Puppa G, Maisonneuve P, Sonzogni A, et al. Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma. Br J Cancer. 2007;96:1118-1126. (Pubitemid 46608324)
33. Rodrigueze-Pinilla SM, Sarrio D, Honrado E, et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinoma. Clin Cancer Res. 2006;12:1533-1539.
34. Roma AA, Prayson RA. Fascin expression in 90 patients with glioblastoma multiforme. Ann Diagn Pathol. 2005;9:307-311. (Pubitemid 41676877)
35. Tong GX, Yee H, Chiriboga L, et al. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder. Hum Pathol. 2005;36:741-746. (Pubitemid 41112028)
36. Tsai WC, Chao YC, Sheu LF, et al. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers. 2007;23:153-160.
37. Vignjevic D, Schoumacher M, Gavert N, et al. Fascin, a novel target for beta-catenin-TCF signalling, is expressed at the invasive front of human colon cancer. Cancer Res. 2007;67:6844-6853. (Pubitemid 47105531)
38. Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80:1529-1537.
39. Xie JJ, Xu LY, Zhang HH, et al. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells. Biochem Biophys Res Commun. 2005;337:355-362.
40. Xue LY, Hu N, Song YM, et al. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of oesophageal squamous cell carcinoma. BMC Cancer. 2006;6:296. (Pubitemid 46178885)
41. Yamashiro S, Yamakita Y, Ono S, et al. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell. 1998;9:993-1006. (Pubitemid 28457295)
42. Yoder BJ, Tso E, Skacel M, et al. The expression of fascin, and actin-bundling motility protein, correlates with hormone-negative breast cancer and a more aggressive clinical course. Clin Cancer Res. 2005;11:186-192. (Pubitemid 40075794)
43. Zhang HH, Xu LY, Kiao D, et al. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol. 2006;59:958-964. (Pubitemid 44422851)
44. Zigeuner R, Droschl N, Tauber V, et al. Biological significance of fascin expression in clear cell renal carcinoma: systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique. Urology. 2006;68:518-522. (Pubitemid 44436491)
45. Zlobec I, Terracciano L, Jass JR, et al. Value of staining intensity in the interpretation of immunohistochemistry for tumor markers in colorectal cancer. Virchows Arch. 2007;451:763-769. (Pubitemid 47497938)